Matthew Lang - 04 Jan 2022 Form 4 Insider Report for Myovant Sciences Ltd.

Reporting relationship: General Counsel & Corp. Secy.
Issuer ticker: N/A
Reported as of: 04 Jan 2022
Net transaction value: -$72,808
SEC form: 4
Accepted by SEC: 06 Jan 2022, 15:46:14 UTC
Prior SEC filing: 07 Oct 2021
Next SEC filing: 07 Apr 2022
Source filing: View source filing
Reporting owner signature: /s/ Matthew Lang

Key filing fact

Matthew Lang filed Form 4 for Myovant Sciences Ltd. on 06 Jan 2022.

Key facts

This page summarizes Matthew Lang's Form 4 filing for Myovant Sciences Ltd..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 06 Jan 2022, 15:46.

Change

Previous filing in this sequence was filed on 07 Oct 2021.
Current net transaction value: -$72,808.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MYOV transaction

Common Shares

Sale

Transaction value: $72,808
Shares: -4,475
Change %: -2.5%
Price: $16.27
Shares after: 175,364
Date: 04 Jan 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.